Recurrence of cardiac sarcoidosis in a heart transplant recipient.
We present the case of a young man who received a left ventricular assist device (LVAD) as a bridge to transplantation for end-stage heart failure, in whom the diagnosis of sarcoid cardiomyopathy was made at the time of LVAD implantation. He subsequently underwent uncomplicated heart transplantation. Nineteen months later, a routine surveillance endomyocardial biopsy specimen demonstrated recurrence of sarcoidosis in the transplanted heart.
Yager
Jonathan E E
JE
Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
Hernandez
Adrian F
AF
Steenbergen
Charles
C
Persing
Bradley
B
Russell
Stuart D
SD
Milano
Carmelo
C
Felker
G Michael
GM
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D016027:Heart Transplantation; D006352:Heart Ventricles / Q000473:pathology; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D009206:Myocardium / Q000473:pathology; D011183:Postoperative Complications / Q000209:etiology*; D011184:Postoperative Period; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D012507:Sarcoidosis / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*
D000893:Anti-Inflammatory Agents; D011241:Prednisone